Biofrontera Inc. (BFRIW) stock
BFRIWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.00+0.00 (0.00%)
Close on Oct 30, 2026Market cap $12.96MP/E –Yield –
Biofrontera ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was -$11.21M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.21M | – |
| FY2024 | Dec 31, 2024 | -$16.79M | – |
| FY2023 | Dec 31, 2023 | -$22.08M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$459.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.27M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.05M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.52M | – |